Comparison Overview
Amgen Oncology

Amgen Oncology
Thousand Oaks, US
Last Update: 19/02/2026
At Amgen, we are committed to the relentless pursuit of breakthroughs for cancer patients and their families. We have a deep and diverse pipeline of cutting-edge therapeutic approaches that aim to improve outcomes. Amgen has been pursuing novel treatment approaches for...

Genentech
1 Dna Way, South San Francisco, California, US, 94080
Last Update: 01/04/2026
About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a differe...
Compliance Ranges Comparison

Amgen Oncology







Genentech






Benchmark & Cyber Underwriting Signals
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Amgen Oncology in 2026.
Incidents vs Biotechnology Research Industry Avg (This Year)
No incidents recorded for Genentech in 2026.
Incident History - Amgen Oncology (X = Date, Y = Severity)
Amgen Oncology cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Genentech (X = Date, Y = Severity)
Genentech cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

Amgen Oncology

Genentech
FAQ
Latest Global CVEs
PraisonAI before 1.5.115 contains a path traversal vulnerability in MultiAgentMonitor that fails to sanitize agent IDs when building file paths. Attackers can include traversal sequences like ../ in agent IDs to read, write, or overwrite arbitrary files, enabling sensitive disclosure, denial of service, or code execution.
PraisonAI before 1.5.115 contains an information disclosure vulnerability in the MultiAgentLedger component that allows attackers to access sensitive data by registering agents with duplicate IDs. Attackers can exploit the lack of agent ID uniqueness enforcement to share ledger instances and expose system prompts and conversation history between agents.
PraisonAI before 1.5.128 contains a cross-origin agent execution vulnerability in the AGUI endpoint that allows remote attackers to trigger arbitrary agent execution. The POST /agui endpoint lacks authentication and hardcodes Access-Control-Allow-Origin: * headers, combined with Starlette's Content-Type-agnostic JSON parsing, enabling attackers to bypass CORS preflight checks via simple requests and exfiltrate sensitive agent responses including tool execution results and environment data.
PraisonAI before 4.5.128 contains an arbitrary shell command execution vulnerability where the UI modules hardcode approval_mode to auto, overriding administrator configuration from PRAISON_APPROVAL_MODE environment variable. Authenticated attackers can instruct the LLM agent to execute arbitrary shell commands via subprocess.run with shell=True, bypassing the manual approval gate and insufficient command sanitization blocklists.
PraisonAI before 1.5.128 caches tool approval decisions by tool name only, not by invocation arguments, allowing subsequent execute_command calls to bypass approval prompts. Attackers can exploit this by obtaining initial approval for a benign command, then silently exfiltrate API keys and credentials via subsequent shell commands without user consent.